HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: J&J v. IGI

This article was originally published in The Rose Sheet

Executive Summary

J&J v. IGI: Johnson & Johnson seeking preliminary and permanent injunction against IGI enjoining the Nova Skin manufacturer from manufacturing, selling, advertising or promoting its new skin care line under the Nova name or "any other name that is confusingly similar to, or which dilutes the uniqueness of, Renova," according to a Feb. 6 complaint. Filed in the U.S. District Court for the District of New Jersey, the complaint alleges that IGI's use of the Nova name infringes J&J's Renova trademark. IGI asserted in a Feb. 15 statement that it would "vigorously defend this lawsuit" and noted that in addition to its federal trademark registration for its Novasome lipid vesicle technology it had several Nova marks outstanding, including Novaspheres "which has been used since 1992 for skin care products." A hearing has been scheduled for March 15...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel